371 related articles for article (PubMed ID: 12168089)
1. Modulation of phospholipase D by Ras proteins mediated by its effectors Ral-GDS, PI3K and Raf-1.
Lucas L; Penalva V; Ramírez de Molina A; Del Peso L; Lacal JC
Int J Oncol; 2002 Sep; 21(3):477-85. PubMed ID: 12168089
[TBL] [Abstract][Full Text] [Related]
2. Regulation of choline kinase activity by Ras proteins involves Ral-GDS and PI3K.
Ramírez de Molina A; Penalva V; Lucas L; Lacal JC
Oncogene; 2002 Jan; 21(6):937-46. PubMed ID: 11840339
[TBL] [Abstract][Full Text] [Related]
3. Ras protein is involved in the physiological regulation of phospholipase D by platelet derived growth factor.
Lucas L; del Peso L; Rodríguez P; Penalva V; Lacal JC
Oncogene; 2000 Jan; 19(3):431-7. PubMed ID: 10656691
[TBL] [Abstract][Full Text] [Related]
4. Involvement of Ral GTPase in v-Src-induced phospholipase D activation.
Jiang H; Luo JQ; Urano T; Frankel P; Lu Z; Foster DA; Feig LA
Nature; 1995 Nov; 378(6555):409-12. PubMed ID: 7477381
[TBL] [Abstract][Full Text] [Related]
5. Ral and Rho-dependent activation of phospholipase D in v-Raf-transformed cells.
Frankel P; Ramos M; Flom J; Bychenok S; Joseph T; Kerkhoff E; Rapp UR; Feig LA; Foster DA
Biochem Biophys Res Commun; 1999 Feb; 255(2):502-7. PubMed ID: 10049738
[TBL] [Abstract][Full Text] [Related]
6. Essential role of Raf in Ras transformation and deregulation of matrix metalloproteinase expression in ovarian epithelial cells.
Ulkü AS; Schäfer R; Der CJ
Mol Cancer Res; 2003 Dec; 1(14):1077-88. PubMed ID: 14707291
[TBL] [Abstract][Full Text] [Related]
7. Regulation of Ras signaling specificity by protein kinase C.
Rusanescu G; Gotoh T; Tian X; Feig LA
Mol Cell Biol; 2001 Apr; 21(8):2650-8. PubMed ID: 11283245
[TBL] [Abstract][Full Text] [Related]
8. The effector loop and prenylation site of R-Ras are involved in the regulation of integrin function.
Oertli B; Han J; Marte BM; Sethi T; Downward J; Ginsberg M; Hughes PE
Oncogene; 2000 Oct; 19(43):4961-9. PubMed ID: 11042683
[TBL] [Abstract][Full Text] [Related]
9. The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho mediated pathways.
Hernandez-Muñoz I; Malumbres M; Leonardi P; Pellicer A
Oncogene; 2000 May; 19(23):2745-57. PubMed ID: 10851075
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase D stimulation by receptor tyrosine kinases mediated by protein kinase C and a Ras/Ral signaling cascade.
Voss M; Weernink PA; Haupenthal S; Möller U; Cool RH; Bauer B; Camonis JH; Jakobs KH; Schmidt M
J Biol Chem; 1999 Dec; 274(49):34691-8. PubMed ID: 10574935
[TBL] [Abstract][Full Text] [Related]
11. Ras-interacting domain of Ral GDP dissociation stimulator like (RGL) reverses v-Ras-induced transformation and Raf-1 activation in NIH3T3 cells.
Okazaki M; Kishida S; Murai H; Hinoi T; Kikuchi A
Cancer Res; 1996 May; 56(10):2387-92. PubMed ID: 8625316
[TBL] [Abstract][Full Text] [Related]
12. A modest reduction in c-myc expression has minimal effects on cell growth and apoptosis but dramatically reduces susceptibility to Ras and Raf transformation.
Bazarov AV; Adachi S; Li SF; Mateyak MK; Wei S; Sedivy JM
Cancer Res; 2001 Feb; 61(3):1178-86. PubMed ID: 11221849
[TBL] [Abstract][Full Text] [Related]
13. Enhanced sensitivity to apoptosis in Ras-transformed thyroid cells.
Cheng G; Meinkoth JL
Oncogene; 2001 Nov; 20(50):7334-41. PubMed ID: 11704863
[TBL] [Abstract][Full Text] [Related]
14. Extracellular signal-regulated activation of Rap1 fails to interfere in Ras effector signalling.
Zwartkruis FJ; Wolthuis RM; Nabben NM; Franke B; Bos JL
EMBO J; 1998 Oct; 17(20):5905-12. PubMed ID: 9774335
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of the Raf-MAPK pathway causes negative feedback inhibition of Ras-PI3K-AKT and cellular arrest through the EphA2 receptor.
Menges CW; McCance DJ
Oncogene; 2008 May; 27(20):2934-40. PubMed ID: 18059341
[TBL] [Abstract][Full Text] [Related]
16. Control of embryonic Xenopus morphogenesis by a Ral-GDS/Xral branch of the Ras signalling pathway.
Lebreton S; Boissel L; Moreau J
J Cell Sci; 2003 Nov; 116(Pt 22):4651-62. PubMed ID: 14576358
[TBL] [Abstract][Full Text] [Related]
17. Elevated levels of ornithine decarboxylase cooperate with Raf/ERK activation to convert normal keratinocytes into invasive malignant cells.
Hayes CS; DeFeo K; Lan L; Paul B; Sell C; Gilmour SK
Oncogene; 2006 Mar; 25(10):1543-53. PubMed ID: 16278677
[TBL] [Abstract][Full Text] [Related]
18. The P34G mutation reduces the transforming activity of K-Ras and N-Ras in NIH 3T3 cells but not of H-Ras.
Oliva JL; Zarich N; Martínez N; Jorge R; Castrillo A; Azañedo M; García-Vargas S; Gutiérrez-Eisman S; Juarranz A; Boscá L; Gutkind JS; Rojas JM
J Biol Chem; 2004 Aug; 279(32):33480-91. PubMed ID: 15181015
[TBL] [Abstract][Full Text] [Related]
19. Ornithine decarboxylase induction in transformation by H-Ras and RhoA.
Shantz LM; Pegg AE
Cancer Res; 1998 Jul; 58(13):2748-53. PubMed ID: 9661886
[TBL] [Abstract][Full Text] [Related]
20. K-Ras promotes growth transformation and invasion of immortalized human pancreatic cells by Raf and phosphatidylinositol 3-kinase signaling.
Campbell PM; Groehler AL; Lee KM; Ouellette MM; Khazak V; Der CJ
Cancer Res; 2007 Mar; 67(5):2098-106. PubMed ID: 17332339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
